Telmisartan Hydrolysis Process Using Phase Transfer Catalysts
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current processes for producing telmisartan are inefficient, requiring lengthy reaction times, low purity, and the use of hazardous chemicals, making them unsuitable for industrial-scale production and pharmaceutical standards.
Innovation Solution
A process involving hydrolysis of tert-butyl ester derivatives in an aqueous basic solution with a polar protic solvent, such as butanol, and using phase transfer catalysts like tetrabutyl ammonium hydrogen sulfate, to produce telmisartan with high purity and yield, reducing the number of reaction steps and energy consumption.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional hydrolysis methods using trifluoroacetic acid and dichloromethane are employed, then telmisartan can be obtained, but the reaction time is lengthy and the purity is low
Solution Approach 1:
The invention changes the chemical parameters of the hydrolysis reaction by using alternative reagents (aqueous base instead of TFA) and solvent systems (polar protic solvents like butanol instead of dichloromethane), which fundamentally alters the reaction pathway and kinetics to achieve both high purity and reduced reaction time
Solution Approach 2:
The invention introduces phase transfer catalysts as intermediaries to facilitate the hydrolysis reaction between aqueous base and organic substrate, enabling the reaction to proceed faster and more efficiently at the interface of immiscible phases, thereby reducing reaction time while maintaining high purity
2Manufacturing precision
If column chromatography is used to purify telmisartan, then pure product is obtained, but the process is time consuming and not economical for industrial scale
Solution Approach 1:
The invention extracts and removes the need for column chromatography by designing a hydrolysis system that inherently produces high-purity product through selective reaction pathways and optimized phase separation, eliminating the time-consuming chromatographic step entirely
Solution Approach 2:
The reaction system self-purifies through selective hydrolysis of the tert-butyl ester group under basic conditions, where the phase transfer catalyst and solvent system work together to automatically favor the formation of pure telmisartan without requiring additional purification operations
3Productivity
If concentrated hydrochloric acid is used for hydrolysis at high temperature, then telmisartan can be produced, but the process is not environmentally friendly and requires acid resistant equipment
Solution Approach 1:
The invention converts the harmful acidic hydrolysis process into a beneficial basic hydrolysis process, where aqueous base solutions replace concentrated HCl, eliminating environmental hazards and equipment constraints while maintaining or improving production efficiency through milder, more sustainable reaction conditions
Solution Approach 2:
The invention fundamentally changes the chemical parameters from acidic to basic conditions, using aqueous bases (NaOH, KOH, etc.) instead of concentrated HCl, which transforms the reaction environment to be environmentally friendly while still achieving efficient hydrolysis and high productivity
4Manufacturing precision
If high boiling solvents like ethylene glycol are used for hydrolysis, then telmisartan can be obtained, but the process is lengthy and not desirable for scaling up
Solution Approach 1:
The invention changes the physical parameters of the solvent system by selecting polar protic solvents with appropriate boiling points (like butanol), which optimize the balance between reaction efficiency, energy consumption, and scalability, avoiding both high-boiling and low-boiling extremes
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves high-purity telmisartan production in a reduced number of steps, suitable for industrial scale, with lower energy and costs, and allows for easy isolation and purification of novel organic salts, resulting in telmisartan with a purity of at least 99.7% HPLC.
Implementation Method 1
hydrolysis of compounds of formula general I, wherein R is tert-butyl ester (Ia)
Implementation Method 2
hydrolysis of compounds of formula general I, wherein R is tert-butyl ester (Ia), or salts thereof in a polar protic solvent
Implementation Method 3
using phase transfer catalysts like tetrabutyl ammonium hydrogen sulfate
Data Source
AI summary
The present invention refers to an improved process for the preparation of telmisartan or a pharmaceutical acceptable salt thereof through hydrolysis compounds of formula general (I) wherein R is tert-butyl ester (Ia) or salts thereof. Preferably, the invention discloses the preparation of telmisartan through hydrolysis of novel organic salts of compounds of formula (I), particularly wherein R is tert-butyl ester (Ia). The invention also relates to a process for the preparation of these novel organic salts, in particular wherein R is tert-butyl ester (Ia) and its use in the preparation of telmisartan.